![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 2, 1105-1111, January 14, 2000
From the Medical Research Council Group in Molecular Endocrinology,
CHUL Research Center and Laval University, Ste-Foy,
Québec G1V 4G2, Canada
Steroid hormones share a very similar structure,
but they behave distinctly. We present structures of human estrogenic
17 The atomic coordinates and the structure factors (code 3dhe and 1dht (for DHEA and DHT complexes, respectively)) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
Dehydroepiandrosterone and Dihydrotestosterone Recognition by
Human Estrogenic 17
-Hydroxysteroid Dehydrogenase
C-18/C-19 STEROID DISCRIMINATION AND ENZYME-INDUCED STRAIN*
,
-hydroxysteroid dehydrogenase (17
-HSD1) complexes with
dehydroepiandrosterone (DHEA) and dihydrotestosterone (DHT), providing
the first pictures to date of DHEA and DHT bound to a protein.
Comparisons of these structures with that of the enzyme complexed with
the most potent estrogen, estradiol, revealed the structural basis and
general model for sex hormone recognition and discrimination. Although the binding cavity is almost entirely composed of hydrophobic residues
that can make only nonspecific interactions, the arrangement of
residues is highly complementary to that of the estrogenic substrate.
Relatively small changes in the shape of the steroid hormone can
significantly affect the binding affinity and specificity. The
Km of estrone is more than 1000-fold lower than
that of DHEA and the Km of estradiol is about 10 times lower than that of DHT. The structures suggest that Leu-149 is
the primary contributor to the discrimination of C-19 steroids and
estrogens by 17
-HSD1. The critical role of Leu-149 has been well
confirmed by site-directed mutagenesis experiments, as the Leu-149
Val variant showed a significantly decreased Km for
C-19 steroids while losing discrimination between estrogens and C-19 steroids. The electron density of DHEA also revealed a distortion of
its 17-ketone toward a
-oriented form, which approaches the transition-state conformation for DHEA reduction.
*
This work was supported by the Medical Research Council of
Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Biophysics and Biophysical Chemistry,
School of Medicine, The Johns Hopkins University, Baltimore, MD 21205.
§
To whom correspondence should be addressed. Tel.: 418-654-2296;
Fax: 418-654-2761; E-mail: sxlin@crchul.ulaval.ca.
This article has been cited by other articles:
![]() |
J. M Day, H. J Tutill, A. Purohit, and M. J Reed Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qiu, M. Zhou, M. Mazumdar, A. Azzi, D. Ghanmi, V. Luu-The, F. Labrie, and S.-X. Lin Structure-based Inhibitor Design for an Enzyme That Binds Different Steroids: A POTENT INHIBITOR FOR HUMAN TYPE 5 17beta-HYDROXYSTEROID DEHYDROGENASE J. Biol. Chem., March 16, 2007; 282(11): 8368 - 8379. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Laurine, D. Lafitte, C. Gregoire, E. Seree, E. Loret, S. Douillard, B. Michel, C. Briand, and J.-M. Verdier Specific Binding of Dehydroepiandrosterone to the N Terminus of the Microtubule-associated Protein MAP2 J. Biol. Chem., August 8, 2003; 278(32): 29979 - 29986. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |